Leadership Overview
Integer Holdings has 5 executives leading key functions including strategy, financial operations, manufacturing, growth, and innovation.
Focused on advancing medical device manufacturing, Integer Holdings delivers high-quality technologies to global OEMs while maintaining a commitment to innovation, collaboration, and patient-centered excellence across diverse energy and medical markets.
Focused on advancing medical device manufacturing, Integer Holdings delivers high-quality technologies to global OEMs while maintaining a commitment to innovation, collaboration, and patient-centered excellence across diverse energy and medical markets.
Leadership Roles at Integer Holdings
Payman Khales - President & Chief Executive Officer
Payman Khales, the President & Chief Executive Officer at Integer Holdings, directs the overarching strategic vision for the global medical device outsource manufacturing operations. Overseeing the cardiac, neuromodulation, and vascular market segments, the President & Chief Executive Officer ensures alignment between manufacturing capabilities and the evolving needs of medical device OEMs. This leadership role involves driving long-term growth initiatives while maintaining the 80-year legacy of innovation associated with the company brands. By fostering a culture of inclusion and integrity, Payman Khales directly impacts the operational success of the organization across international markets. Khales coordinates with the board to execute high-level business objectives, ensuring that the company remains a leader in providing critical technologies that enhance patient lives worldwide. Ultimately, the President & Chief Executive Officer secures the competitive position of the firm through disciplined execution and a focus on customer-centric manufacturing excellence.

Steven Schaepe - Chief Financial Officer & Executive VP, Corporate Development
Steven Schaepe, the Chief Financial Officer & Executive VP, Corporate Development at Integer Holdings, manages the financial health and strategic expansion efforts of the organization. Overseeing capital allocation and corporate development, the Chief Financial Officer & Executive VP, Corporate Development ensures that investments align with the long-term goals of the cardiac and portable medical markets. This leadership role involves evaluating potential acquisitions and partnerships that strengthen the market position of the company. By optimizing financial reporting and fiscal discipline, Steven Schaepe directly impacts the ability of the firm to scale manufacturing operations globally. Schaepe collaborates with the executive team to maintain transparency and integrity in all financial dealings. Ultimately, the Chief Financial Officer & Executive VP, Corporate Development drives sustainable value creation for shareholders while supporting the broader mission of delivering innovative medical device solutions to customers across the energy and healthcare sectors.
Diron Smith - Executive VP & Chief Financial Officer
Diron Smith, the Executive VP & Chief Financial Officer at Integer Holdings, oversees the financial planning, treasury functions, and risk management strategies for the enterprise. Managing the fiscal infrastructure, the Executive VP & Chief Financial Officer ensures that the company maintains the liquidity necessary to support ongoing innovation in the medical and energy markets. This leadership role involves analyzing market trends and financial performance to guide the strategic decision-making of the executive team. By implementing robust financial controls, Diron Smith directly impacts the stability and growth trajectory of the organization. Smith works closely with the audit committee and external stakeholders to ensure compliance and financial integrity. Ultimately, the Executive VP & Chief Financial Officer provides the analytical foundation required to sustain the 80-year legacy of the company, ensuring that resources are effectively deployed to meet the demands of global medical device OEMs and niche energy applications.

Jeremy Friedman - Executive Vice President & Chief Operating Officer
Jeremy Friedman, the Executive Vice President & Chief Operating Officer at Integer Holdings, directs the daily manufacturing and operational workflows across all global facilities. Overseeing the production of high-quality medical devices and niche energy batteries, the Executive Vice President & Chief Operating Officer ensures that operational efficiency meets the rigorous standards required by medical device OEMs. This leadership role involves streamlining supply chain logistics and manufacturing processes to support the cardiac, neuromodulation, and vascular markets. By implementing lean manufacturing principles, Jeremy Friedman directly impacts the output quality and delivery timelines for critical patient-care technologies. Friedman coordinates with regional plant managers to maintain consistent operational excellence across the international footprint of the company. Ultimately, the Executive Vice President & Chief Operating Officer optimizes internal resources to support the growth of the business while upholding the core values of innovation and customer service.
Andrew Senn - President, Growth & Innovation
Andrew Senn, the President, Growth & Innovation at Integer Holdings, leads the research and development initiatives aimed at expanding the technological capabilities of the company. Overseeing the pipeline of new product development, the President, Growth & Innovation ensures that the firm remains at the forefront of the cardiac, neuromodulation, and vascular markets. This leadership role involves identifying emerging opportunities in the portable medical and energy sectors to drive future revenue streams. By fostering a culture of innovation and collaboration, Andrew Senn directly impacts the ability of the company to provide cutting-edge solutions to medical device OEMs. Senn coordinates with engineering and marketing teams to translate complex technical requirements into market-ready products. Ultimately, the President, Growth & Innovation secures the long-term relevance of the organization by continuously pushing the boundaries of manufacturing excellence and developing industry-changing technologies that improve patient outcomes on a global scale.

Explore Leadership Teams in Manufacturing
Medtronic is a global healthcare technology company founded in 1949 that develops and manufactures medical devices, therapies, and digital health solutions. Its portfolio spans cardiovascular, neuroscience, medical surgical, and diabetes technologies. Operating in more than 150 countries, the company collaborates with healthcare providers to improve patient outcomes through innovative products and services that diagnose, prevent, and treat a wide range of chronic diseases and medical conditions.
Company Leadership
DS

SS
Founded in 2001, Aeroflow Health is a pioneering healthcare company that leverages cutting-edge technology to support the delivery of medical products and services. With a steadfast commitment to empowering patients and improving their understanding of benefits, Aeroflow Health provides a curated experience for every individual and group. Offering a comprehensive portfolio of high-quality products, Aeroflow Health is dedicated to enhancing health outcomes and closing care gaps, ensuring that patients receive the care they deserve. Aeroflow's commitment to accessible healthcare has resulted in partnerships.
Company Leadership
LB
CW
ZOLL, founded in 1980, is a medical device manufacturer that develops innovative technologies for diagnosing and treating cardiopulmonary and respiratory conditions. The company produces a comprehensive range of medical devices, software solutions, and related services that are utilized by healthcare providers globally. ZOLL's product portfolio includes advanced life support equipment, automated external defibrillators, and monitoring systems designed to improve patient outcomes in critical care situations. With operations across North America, Europe, Asia, and other global regions, ZOLL maintains a strong focus on medical technology innovation in the healthcare sector.
Company Leadership EK
SR
SS
EL
As per the "buy and build" strategy, the next acquisition was Legacy Medical (July 2018), followed by Haemotec (Nov 2019) and LTE Medical Supplies (Feb 2019). In April 2019, the company started an Ophthalmology business (EyeCare) and have expanded the company's product range and agencies in the existing verticals. The second half of 2019 saw further acquisitions with Paragmed in November and Jumla Medical Supplies and Stratmed joining the group in December. The company is a scaled and diversified group of specialised medical service providers committed to bringing new, first-rate technologies to a wide spectrum of medical practitioners. The company provides the latest devices, software, processes and procedures that facilitate high care and quality treatment for all patients. The company's clients and partners continually receive extensive training and comprehensive technical support as the company strives towards better products, better services and more personalised customer experiences. Depiction of Vertice MedTech
Company Leadership HP
GS
BM
EM